Primary Site >> Pancreatic Cancer

Gene >> NR1I3

Journal: Mol Ther. 2017 Jan 4;25(1):259-273.
Title: Targeting of Aberrant alphavbeta6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells.
Author: Whilding, Lynsey M|Parente-Pereira, Ana C|Zabinski, Tomasz|Davies, David M|Petrovic, Roseanna M G|Kao, Y Vincent|Saxena, Shobhit A|Romain, Alex|Costa-Guerra, Jose A|Violette, Shelia|Itamochi, Hiroaki|Ghaem-Maghami, Sadaf|Vallath, Sabari|Marshall, John F|M
PMID: 28129120
Journal: J Surg Oncol. 2017 Jul;116(1):63-74.
Title: CAR T-cell therapy for pancreatic cancer.
Author: DeSelm, Carl J|Tano, Zachary E|Varghese, Anna M|Adusumilli, Prasad S
PMID: 28346697
Journal: Cancer Discov. 2018 Aug;8(8):972-987.
Title: Enhancing the Potency and Specificity of Engineered T Cells for Cancer Treatment.
Author: Sukumaran, Sujita|Watanabe, Norihiro|Bajgain, Pradip|Raja, Kanchana|Mohammed, Somala|Fisher, William E|Brenner, Malcolm K|Leen, Ann M|Vera, Juan F
PMID: 29880586
Journal: Front Immunol. 2018 Sep 25;9:2166.
Title: The Potential of CAR T Cell Therapy in Pancreatic Cancer.
Author: Akce, Mehmet|Zaidi, Mohammad Y|Waller, Edmund K|El-Rayes, Bassel F|Lesinski, Gregory B
PMID: 30319627